Objective: To determine if levels of the adipocyte-derived hormone, leptin, predict the development of type 2 diabetes. Methods: Population-based surveys were undertaken in the multiethnic nation of Mauritius in 1987Mauritius in , 1992Mauritius in and 1998. Questionnaires, anthropometric measurements, and a 2-h 75-g oral glucose tolerance test were included. A cohort of 2330 participants who were free of diabetes, aged 25-79 years in 1987, and who were followed-up in 1992 and 1998 was studied. Serum leptin was measured in baseline samples. Glucose tolerance was classified according to WHO (World Health Organization) 1999 criteria. Results: In total, 456 subjects developed diabetes over 11 years with similar incidences in all ethnic groups (P ¼ 0.2). Baseline leptin correlated positively with anthropometric measurements, fasting and postload insulin and homeostasis model assessment indices (all Po0.001), and inversely with subsequent weight increase. Participants with incident diabetes had higher serum levels of leptin at baseline than those remaining nondiabetic (Po0.001). After adjustment for confounders, high leptin levels and high leptin/body mass index ratio were independently associated with incident diabetes over 11 years in men (odds ratio for top versus bottom quartile of leptin 2.18; 95% CI: 1.09-4.35), but not in women. Conclusion: We conclude that high leptin levels are associated with the future development of diabetes, and the association is independent of other factors in men, but not in women.
Introduction
Obesity is related to reduced insulin sensitivity, hyperinsulinemia and an increased risk of glucose intolerance. 1 The actual mediators increasing the risk of glucose intolerance in relation to obesity and the insulin resistance syndrome are not fully understood. 2 During the last decade, it has been established that fat tissue has many important metabolic and endocrine functions. Adipocyte-derived hormones such as leptin and adiponectin have been shown to be important regulators of insulin sensitivity, glucose tolerance, 3, 4 vessel integrity 5, 6 and lipid metabolism. 7, 8 Leptin is important for the 'communication' between fat tissue and several metabolic pathways. Leptin deficiency in the ob/ob mice causes severe obesity, insulin resistance and the development of glucose intolerance. 9 In contrast, obesity in humans is characterized by high circulating levels of leptin owing to reduced sensitivity to leptin (leptin resistance) and leptin deficiency is a very rare cause of obesity in humans. 10 Flier 9 has suggested that leptin is important for the adaptation of metabolic and hormonal pathways during starvation and high levels may thus be physiologically inappropriate. This is supported by mounting experimental evidence showing that leptin may have detrimental effects on the cardiovascular system 6 and the insulin producing bcell. 11 Indeed, we and others have shown that leptin is an independent predictor of type 2 diabetes 12 and cardiovascular disease 13 in men, but not women.
Functional leptin receptors are expressed on the b-cell, 11, 14 which could mediate effects on insulin secretion. Furthermore, leptin relates experimentally to apoptosis of b-cells 15 and to the inflammatory response in islets. 16 In addition, leptin may decrease insulin sensitivity 3 and could thus lead to declining glucose tolerance. In this study, we hypothesized that leptin is an independent predictor of glucose intolerance and by extending the analysis from our previous work, 2 in which we showed that leptin predicted incident diabetes over 5 years, we examined the impact of leptin over a longer period of time. Furthermore, we aimed to determine if the impact of leptin differs between men and women in the context of other anthropometric and biochemical variables related to obesity and increased risk for diabetes.
Methods
Background and subjects Mauritius is a subtropical island located in the Southwestern Indian Ocean with a population of about 1.2 million. The multiethnic population consists of 68% individuals of Asian Indian origin, 3% individuals of Chinese origin and 27% are of the general population, which mainly comprises people with mixed African and Malagasy ancestry with some European and Indian admixture (Creoles).
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Details of the survey methodology and procedures have previously been published. [18] [19] [20] [21] In 1987, 10 randomly selected (with probability proportional to size) population clusters (based on the 1983 census) and a purposely selected area of Chinatown in the capital, Port Louis, were surveyed. All eligible adults were invited and 5083 participated (86% response rate). Follow-up surveys were performed in 1992 and 1998. Nonpregnant participants without diabetes aged between 25 and 79 years and in 1987, and with classifiable data from 1987 and 1998 were included in this analysis (n ¼ 2330, 46% of the participants in 1987 (30 were pregnant 1987 or 1998, 134 had non-classifiable data for glucose tolerance and 301 had diabetes in 1987)). The cohort was representative of the population, with 70% Indians, 25% Creoles and 5% Chinese subjects. The characteristics of this cohort compared to those lost to follow-up have previously been presented. 22, 23 The survey protocol was reviewed and approved by the local ethics committee (Melbourne, Australia).
Survey procedures
All eligible adults were asked to attend a survey site between 0800 and 1000 h after an overnight fast. Trained local nurses administered a questionnaire and anthropometric measurements were carried out. Body mass index (BMI) and waisthip ratio (WHR) were calculated based on measurements of height, weight and waist and hip circumferences, and detailed descriptions of anthropometric measurements have been previously published. 21 Seated blood pressure was measured and hypertension was defined as systolic blood pressure X140 mm Hg and/or diastolic blood pressure X90 mm Hg and/or on self-reported antihypertensive medication. 24 Ethnicity was determined by self report. Smokers were those reporting current smoking at the time of the survey, former smokers and never smokers were thus treated as the reference category. All participants not taking diabetes medication had a 2-h 75 g oral glucose (glucose monohydrate) tolerance test. Fasting and 2-h venous blood samples were centrifuged and separated immediately. Glucose assays and adjustments have been described previously. 22 Glucose tolerance status was determined according to 1999 WHO (World Health Organization) criteria. 25 Diabetes was diagnosed if subjects reported taking hypoglycemic medication or the fasting plasma glucose level was X7.0 mmol/l and/or the 2-h value was X11.1 mmol/l. Subjects with a fasting plasma glucose o7.0 mmol/l but a 2-h value from X7.8 mmol/l to o11.1 mmol/l were defined as having impaired glucose tolerance (IGT). Subjects with a fasting plasma glucose from X6.1 mmol/l to o7.0 mmol/l but a 2-h value o7.8 mmol/l were categorized as having impaired fasting glucose (IFG). Fasting and 2-h insulin were measured in serum transported on dry ice to Newcastle upon Tyne, UK. 18 A modified radioimmunoasay (RIA) method proposed by Soeldner and Slone 26 was used. The interassay and intraassay coefficients of variation (CV) were 6 and 4%, respectively. Cross reactivity with intact proinsulin and 32,33-split proinsulin was 27 and 16%, respectively. An estimate of insulin sensitivity and b-cell function was obtained by using a modification of the homeostasis model assessment (HOMA). 27 Total cholesterol, triglycerides and high-density lipoprotein (HDL) concentrations were determined in fresh heparin plasma by manual enzymatic methods at the Victoria Hospital in Mauritius. 19 External quality assurance on every 10th sample was undertaken in Newcastle upon Tyne, UK, and cholesterol and triglyceride levels were consistently overestimated across the distribution and were adjusted downwards using a calculated regression equation. Dyslipidemia was defined as triglycerides X1.7 mmol/l and/ or HDL cholesterol o0.9 mmol/l for men or o1.0 mmol/l for women. Leptin was measured in Melbourne, Australia, in 1996 by a RIA (Linco, St Charles, MO, USA). The lower limit of detection with this assay was 0.5 ng/ml and interassay and intraassay CVs were 4.1-8.2% and 4.2%, respectively. The leptin/BMI ratio was calculated as one method of accounting for the relationship between obesity and leptin.
Statistical analysis
A reference population was defined, and included those who maintained normal glucose tolerance (NGT) between 1987 and 1998. The distribution of continuous variables in this population was used for calculating cutoffs for quartiles, separately for men and women. For the correlation analysis, continuous variables were ln-transformed to improve skewness and kurtosis. Age and ethnicity adjusted means with 95% confidence intervals (CIs) or proportions are presented.
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The significance of any group differences was tested by an analysis of variance including adjustments and Bonferroni correction. Bivariate (Pearson's) and partial correlation coefficients were calculated, adjusted for age, sex and adiposity. The influence of studied variables on glucose intolerance (stratified for sex) was tested by univariate and multivariate logistic regression analysis to estimate the odds ratios (ORs) and 95% CIs. Linear trend for the distribution of cases and referents in quartiles of leptin were tested with a w 2 test. P-values o0.05 were considered significant. All calculations were performed with SPSS (Chicago, IL, USA) version 11.0.
Results
There were 301 participants excluded from the 1987 to 1998 cohort because of diabetes at baseline. The characteristics of the remaining participants (classified as NGT, IFG or IGT at baseline) according to their outcome after 11 years are shown in Table 1 . Men and women with incident diabetes in 1998 were older, more obese, and were more likely to have hypertension and dyslipidemia at baseline in 1987 than were those remaining nondiabetic. Furthermore, they had higher levels of fasting and postload levels of glucose and insulin, and accordingly, their estimated insulin sensitivity (HOMA-S) was lower and their estimated b-cell function (HOMA-B) was higher. Men and women who developed diabetes had higher leptin levels than those remaining nondiabetic, whereas leptin/BMI ratio was higher only in men. Indians with incident diabetes were younger (Po0.05) and had higher blood pressure (Po0.05) and postload insulin (Po0.05) levels compared to Creoles. Notably, obesity indices did not differ between ethnicities in those developing diabetes. The incidence of diabetes was similar in all ethnic groups (P ¼ 0.21).
In those with NGT at baseline, adjusted (age and ethnicity) leptin levels in men converting in diabetes were higher than in men converting in IGT (Po0.05) or IFG (P ¼ 0.002) or remaining NGT (Po0.001). In women, those with incident diabetes had higher leptin levels than women remaining NGT (Po0.05). Leptin levels remained significantly higher in men with incident diabetes than those remaining NGT also after further adjustment for BMI (Po0.05). The leptin/BMI ratio was also significantly higher in men with incident diabetes compared to those with NGT (Po0.001), whereas levels where unrelated to the development of diabetes in women.
At Values given are numbers (n), means or percentages with 95% CIs, and differences between groups (ANOVA). All means and percentages are adjusted for age and ethnicity.
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Risk markers for future development of diabetes over 11 years are presented in Table 2 . The risk for incident diabetes was similar in men and women and similar in all ethnic groups. Notably a BMI over 20 in both men and women, and a waist circumference above 76 cm in men and 70 cm in women were significantly related to increased risk for incident diabetes (data not shown). Waist circumference was associated with diabetes after adjustment for BMI in both men and women, whereas the risk related to BMI was markedly attenuated after adjustment for waist in women. High levels of fasting and postload glucose and insulin, . Leptin remained associated with incident diabetes in men after adjustment for family history of diabetes, level of physical activity and socioeconomic factors (income and level of education) in separate models including age, ethnicity and obesity (data not shown). The leptin/BMI ratio gave similar results with independent associations with incident diabetes in men ( Table 4) . When analysing Indians and Creoles separately, the OR for men remained similar, but were only significant for the leptin/BMI ratio in Indian men (Indian men: To explore whether the male-female differences in the associations of leptin with incident diabetes were simply owing to the higher leptin levels seen in women (see Table 1 ), the top quartile of men was dichotomized around its median value (6.0 ng/ml), hence approximating to the comparison between Q1 and Q2 in women. The OR of incident diabetes for those men above vs those below this cutpoint was 1.77 (1.11-2.83). This was slightly attenuated after adjustment for obesity [1.57 (0.96-2.56)].
Waist circumference was chosen as the obesity measure owing to the strong association with diabetes in the univariate analysis. However, adjustment for BMI in model 1 did not alter the association between leptin and future development of diabetes (data not shown), whereas the association was attenuated in models 2 (P ¼ 0.08) and 3 (P ¼ 0.09). Notably, adjustments for both obesity variables simultaneously seemed to suffer from colinearity, especially in men. Similarly, waist circumference and fasting insulin suffered from colinearity in women and were not possible to enter simultaneously in models 2 and 3. High leptin levels remained also associated with incident diabetes in men after adjusting for both baseline and further increase in BMI or waist over 11 years (data not shown).
Discussion
In this paper, we report that high leptin levels are associated with future development of diabetes, and that the association is independent of other factors in men, but not in women. In a previous report, we reported a nonlinear relation between increasing leptin levels and risk for IGT or diabetes in Mauritius over 5 years in a nonstratified analysis. 2 In this paper, we expand those findings in a larger cohort followed for a longer period. An independent association between high leptin levels and the risk for future diabetes has also been shown in Japanese Americans. 12 Interestingly, the risk associated with leptin was only seen in centrally obese men in that study. Estimated insulin resistance was not associated with future glucose intolerance once adjusted for leptin in either of these two studies and b-cell function was not included. Crosssectionally, leptin levels in type 2 diabetic patients are similar to those in nondiabetic subjects. 28 However, patients with newly diagnosed and poorly controlled diabetes have lower concentrations 29, 30 and this has been attributed to low insulin levels. The adipocyte-derived hormone leptin has been related to numerous metabolic and endocrine processes, but its exact physiological function remains unclear. The normal function of leptin may perhaps be found in the context of starvation and irregular supply of food. 9 High levels could therefore be out of the physiological range at best and possibly also be harmful. As human obesity is characterized by high circulating levels of leptin, it is postulated that the normal leptin signalling counteracting obesity could be defective, that is, leptin resistance. This concept implies also that physiological processes normally depending on leptin signalling could be defective owing to downregulation of the signalling process from overloading the system, and pathological effects attributed to leptin could thus be owing to lack of normal leptin action. The integrity of the pancreatic islets has been related to adipose tissue and the presence of an adipoinsular axis has been postulated, as the morphology of the adipocytes rather than the number of fat cells relates to the b-cells function. 31, 32 Changes in the intrauterine milieu such as fetal malnutrition 33 and exposure to androgens 34 may induce dysfunction of this axis that will later in life manifest itself as diabetes and cardiovascular disease. Both insulin and leptin fit well with this concept and are plausible bidirectional mediators. 11, 14 Experimentally, insulin seems to be the main regulator of leptin production and chronic insulin stimulation is followed by hyperleptinemia. The association between leptin and insulin also implies that leptin may affect the insulin-producing b-cell. Indeed, leptin receptors are expressed on the b-cell. However, the effect on insulin secretion is not established, as several studies have shown an inhibitory effect, but also stimulatory and no effects have been reported. It is possible that the intracellular content of triglycerides will determine the effect, 35 and that leptin reduces the triglyceride burden, which at least in a rat model was followed by increased insulin secretion. 36 Consequently, it has been suggested that leptin regulates the metabolism of fatty acids in nonadipose tissue, 37 but owing to dysfunction in leptin signalling, i.e. leptin resistance, this function may not work properly in obesity and reduced b-cells function follows. 38 In our own studies, we have observed that the relationship between leptin and insulin differs between subjects with and without abdominal obesity. 39 This could be a sign of decreased inhibition of insulin secretion with increasing obesity, 11, 14 and the resulting hyperinsulinemia will further stimulate leptin production and obesity will thus be associated with both high leptin and insulin levels. In addition, reduced leptin effects on b-cell apoptosis 15 and NO release 40 owing to leptin resistance could further harm b-cell viability and function. Related to the potentially negative impact on b-cell function, leptin also stimulates the immune system towards a cellular response, 41 and it has been shown that leptin accelerates the inflammatory process seen in islets from the NOD mice, 16 notably only in female mice. Our finding of a sex difference in the role of leptin has been apparent in other populations. 12, 13 Interestingly, the brains of male and female rats are differentially sensitive to the catabolic actions of small doses of leptin (and insulin) with higher sensitivity in female rats, 42 and estrogens can alter the hypothalamic sensitivity for leptin, 43 possibly by Leptin predicts diabetes S Söderberg et al stimulating the expression of the long leptin receptor. 44 As leptin levels are higher in females, this suggests that differences in leptin transport over the blood-brain barrier or differences in intracellular signalling cascades may exist. Whether or not this is relevant for the peripheral effects of leptin described in this study is to our knowledge unknown. An alternative explanation for the lack of an independent association of leptin with incident diabetes in women relates to the higher levels of leptin in women, suggesting the possibility that the relationship between serum leptin levels and diabetes is nonlinear, with a plateau above a certain level. However, although the overlap of leptin levels between men and women was limited, when we dichotomized the top quartile of men, the cutpoint was similar to that between the two bottom quartiles of women, and in men, the risk of diabetes was higher in the upper than the lower group. This risk approached statistical significance after adjusting for confounders. In contrast, for women, the risk associated with being in the 2nd vs the 1st quartile disappeared after adjustments, suggesting that leptin indeed has differential effects in men and women. Furthermore, leptin normalized for BMI (leptin/BMI ratio) independently associated with incident diabetes in men irrespective of ethnic background. However, the results related to sex differences should be interpreted with caution as leptin and measures of obesity are so strongly associated and it is questionable if models exploring the effect of leptin or other obesity-related cytokines should be adjusted for obesity. We have however taken all possible actions to explore these interactions within the limits of a large population based study where other measures than anthropometry are not feasible. Furthermore, we are full aware of that it is still possible that leptin is just another measure of obesity, and the risk related to leptin reported in this study is a reflection of the impact of obesity. However, these results are consistent with findings from other populations, 12, 13, 45 with more advanced adjustments for obesity 12 and for other outcomes such as myocardial infarction and stroke. 13, 45 The detrimental effect of obesity (and central obesity in particular) on future risk for diabetes is clearly demonstrated in this study, and that levels of BMI and waist circumference considered as normal implies increased risk in populations of Asian and African background.
In summary, we show in this study that leptin predicts development of diabetes over 11 years, independently of other risk factors in men.
